International Cannabis Weekly: 431

CANNABIS RESCHEDULING IS HERE: TRUMP SIGNS EXECUTIVE ORDER TO MOVE CANNABIS TO SCHEDULE III

After two years of speculation, rumours, stock swings, broken promises, and political theatre, President Donald Trump officially signed an executive order (EO) to push cannabis rescheduling through on Thursday (December 18).

READ MORE  »

FIRST READING OF AMENDMENT TO MEDCANG IN GERMANY TAKES PLACE

READ MORE »

CBD COMPANY FOUNDER WINS £137K UNFAIR DISMISSAL AWARD AMID CANNIM GROUP COLLAPSE

READ MORE »

• Glass Pharms announces new UK supply deals with premium medical cannabis range for clinics and pharmacies.
• Hamburger cannabis cultivation association fails to secure approval amid alleged administrative arbitrariness.
• German cannabis industry group warns hundreds of pharmacies face threat under new regulatory changes.
• In the UK’s medical cannabis market the winner takes all dynamic is shaping competition.
• Finnish left alliance major party officially endorses adult cannabis legalisation and regulated distribution model.
• Over fifty three thousand peer reviewed scientific articles on cannabis research now indexed on PubMed.
• Evolving cannabis policy and trends across Europe amid regulatory debates.
• Spain’s medical cannabis decree legal on paper but remains bottlenecked in real world practice.
• CBD market in Spain grows annually by thirty five percent but regulatory gaps stall progress.
• Malta has set a legal cannabis driving limit through new drug driving bill in parliament.

SEE FULL AGENDA »

• Bipartisan senators discuss cannabis industry banking issues as Trump considers rescheduling classification.
• Dozens of Alabama doctors prepare to recommend medical cannabis under new healthcare guidance.
• Legacy cannabis brand announces California sales partnership to expand retail and product reach.
• Weed Inc forms strategic blockchain partnership with Remergify to design decentralised cannabis solutions.
• Kentucky’s first medical cannabis dispensary opens doors in Beaver Dam to patients and community.
• Cannabis cafes could soon open across Massachusetts with regulatory push gaining momentum.
• Major legal developments are affecting cannabis businesses and policy landscapes nationally.
• Texas opens its largest medical cannabis facility in Bastrop signalling industry growth in the state.

• Canopy Growth to acquire MTL Cannabis expanding company breadth and Quebec presence in national market.
• Cannabis gummies sold in Ontario recalled over incorrect labels creating safety concerns for consumers.
• High demand drives Sidney to consider adding another cannabis retailer on Beacon Avenue.
• Market movers include Oracle, RH, Canopy Growth and Aurora Cannabis in Canadian cannabis equities.
• AGLC announces changes to cannabis promotion rules affecting marketing across Alberta and regional operators.
• Organigram reports net revenue climbs in 2025 fuelled by domestic and international cannabis sales growth.

• Brazilian study investigates the safety and use of cannabidiol in children with autism spectrum disorder.
• Anvisa prohibits sale and advertising of unregistered cannabis oil products across Brazil.
• KCBD and CONICET sign agreement to investigate therapeutic potential of medicinal cannabis.
• Bioxyne inks first mover supply deal to tap emerging Central American cannabis markets.

• Medicinal cannabis approvals and industry developments discussed in new ABC News report from Australia.
• Epsilon and former chairman told to mediate in bid to settle cannabis industry dispute in Australia.
• AMCA and MCIA reveal new name for merged cannabis industry body in Australia.
• UIC conference returns with expanded program and discounts for Cannabiz readers in Australia.

• IM Cannabis Corp’s stock surges despite its low price to sales ratio raising investor questions.
• Morocco aims to boost legal cannabis farming and tap a global boom.